Clinical Trials Logo

Clinical Trial Summary

This study aimed to investigate the effectiveness of CoronaVac vaccine, which is more than 90% protective in healthy people, in cancer patients receiving active chemotherapy. In this study, to collect information to measure the amount of antibodies produced by the vaccine in the blood of volunteers with the CoronoVac vaccine and to compare it with healthy volunteers.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Is the Coronovac Vaccine Effective in Patients Receiving Chemotherapy

NCT number NCT04765215
Study type Observational
Source Namik Kemal University
Contact
Status Active, not recruiting
Phase
Start date March 31, 2021
Completion date March 31, 2022